Mutations in the KCNK3 gene, which encodes the potassium channel TASK-1 [12], and in KCNA5, which encodes the voltage-dependent potassium channel Kv1.5, have also been identified in PAH patients [13]. This evidence concerns the gene KCNA5 and pulmonary arterial hypertension.